DK0505379T3 - Muscarin-receptor-antagonister - Google Patents

Muscarin-receptor-antagonister

Info

Publication number
DK0505379T3
DK0505379T3 DK90917103.5T DK90917103T DK0505379T3 DK 0505379 T3 DK0505379 T3 DK 0505379T3 DK 90917103 T DK90917103 T DK 90917103T DK 0505379 T3 DK0505379 T3 DK 0505379T3
Authority
DK
Denmark
Prior art keywords
alkyl
pct
independently
receptor antagonists
date jun
Prior art date
Application number
DK90917103.5T
Other languages
Danish (da)
English (en)
Inventor
Alexander Roderick Mackenzie
Peter Cross
Original Assignee
Pfizer
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Pfizer Ltd filed Critical Pfizer
Application granted granted Critical
Publication of DK0505379T3 publication Critical patent/DK0505379T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90917103.5T 1989-12-12 1990-11-28 Muscarin-receptor-antagonister DK0505379T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928043A GB8928043D0 (en) 1989-12-12 1989-12-12 Muscarinic receptor antagonists

Publications (1)

Publication Number Publication Date
DK0505379T3 true DK0505379T3 (da) 1994-09-12

Family

ID=10667814

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90917103.5T DK0505379T3 (da) 1989-12-12 1990-11-28 Muscarin-receptor-antagonister

Country Status (13)

Country Link
US (1) US5300516A (fi)
EP (1) EP0505379B1 (fi)
JP (1) JPH0686428B2 (fi)
AT (1) ATE108776T1 (fi)
CA (1) CA2067759C (fi)
DE (1) DE69010917T2 (fi)
DK (1) DK0505379T3 (fi)
ES (1) ES2057601T3 (fi)
FI (1) FI96024C (fi)
GB (1) GB8928043D0 (fi)
IE (1) IE63421B1 (fi)
PT (1) PT96142B (fi)
WO (1) WO1991009014A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602516D0 (en) * 1996-02-08 1996-04-10 Chiroscience Ltd Racemisation
DE10002509A1 (de) * 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
US20180344735A1 (en) * 2015-12-14 2018-12-06 Ironwood Pharmaceuticals, Inc. USE OF sGC STIMULATORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER DYSFUNCTION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664424A (en) * 1953-12-29 Dioxo-piperidines
US2848455A (en) * 1955-07-18 1958-08-19 Ciba Pharm Prod Inc Alpha-(p-amino-phenyl)-alpha-lower alkyl glutarimides
BE632403A (fi) * 1962-05-17 1900-01-01
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
GB8716338D0 (en) * 1987-07-10 1987-08-19 Nat Res Dev Anti-anxiogenic compositions

Also Published As

Publication number Publication date
US5300516A (en) 1994-04-05
PT96142A (pt) 1991-09-30
ES2057601T3 (es) 1994-10-16
FI96024C (fi) 1996-04-25
FI922342A0 (fi) 1992-05-22
WO1991009014A1 (en) 1991-06-27
CA2067759A1 (en) 1991-06-13
DE69010917D1 (de) 1994-08-25
EP0505379A1 (en) 1992-09-30
DE69010917T2 (de) 1994-11-03
EP0505379B1 (en) 1994-07-20
FI96024B (fi) 1996-01-15
JPH04505926A (ja) 1992-10-15
GB8928043D0 (en) 1990-02-14
ATE108776T1 (de) 1994-08-15
CA2067759C (en) 1996-09-10
IE904461A1 (en) 1991-06-19
PT96142B (pt) 1997-05-28
IE63421B1 (en) 1995-04-19
JPH0686428B2 (ja) 1994-11-02
FI922342A (fi) 1992-05-22

Similar Documents

Publication Publication Date Title
DE69014901D1 (de) Muscarin-rezeptor-antagonisten.
WO1992005172A3 (en) Muscarinic receptor antagonists
DK0510003T3 (da) Piperidin-og pyrrolidinderivater
ATE102183T1 (de) Muscarin-rezeptor-antagonisten.
ATE64373T1 (de) Muscarin-rezeptor-antagonisten.
ATE108776T1 (de) Muscarin-rezeptor-antagonisten.
ATE101599T1 (de) Muscarin-rezeptor-antagonisten.